Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
<p>Congenital myasthenic syndromes (CMS) are a rare group of heterogeneous disorders, characterised by compromised neuromuscular transmission and symptoms of fatiguable muscle weakness. CMS is caused by mutations in genes that affect the structure and function of the ne...
Main Author: | Clausen, L |
---|---|
Other Authors: | Beeson, D |
Format: | Thesis |
Language: | English |
Published: |
2015
|
Similar Items
-
DOK7 congenital myasthenic syndrome.
by: Palace, J
Published: (2012) -
Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
by: Müller, J, et al.
Published: (2007) -
Dok-7/MuSK signaling and a congenital myasthenic syndrome.
by: Yamanashi, Y, et al.
Published: (2008) -
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010) -
Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
by: Vanhaesebrouck, A
Published: (2018)